Search research articles
Contact Us
Filters
Showing results (121-130 of 212) with videos related to
Page
of 22
Sort By:
Haematologica
|
April 6, 2006
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease
Andrea Gallamini, Luigi Rigacci, Francesco Merli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2007
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study
Andrea Gallamini, Martin Hutchings, Luigi Rigacci, et al.
Haematologica
|
August 19, 2021
Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study
Lale Kostakoglu, Federico Mattiello, Maurizio Martelli, et al.
The Journal of Molecular Diagnostics : JMD
|
August 31, 2015
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR
Daniela Drandi, Lenka Kubiczkova-Besse, Simone Ferrero, et al.
Haematologica
|
July 10, 2009
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study
Umberto Vitolo, Annalisa Chiappella, Emanuele Angelucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project
Massimo Federico, Monica Bellei, Luigi Marcheselli, et al.
Haematologica
|
July 2, 2013
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi
Annalisa Chiappella, Alessandra Tucci, Alessia Castellino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2013
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi
Massimo Federico, Stefano Luminari, Alessandra Dondi, et al.
Haematologica
|
November 8, 2011
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers
Francesco Zaja, Stefano De Luca, Umberto Vitolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2019
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
Magdalena Klanova, Mikkel Z Oestergaard, Marek Trněný, et al.
Page
of 22
Search research articles
Search
Showing results (121-130 of 212) with videos related to
Sort By:
Page
of 22
Haematologica
|
April 6, 2006
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease
Andrea Gallamini, Luigi Rigacci, Francesco Merli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2007
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study
Andrea Gallamini, Martin Hutchings, Luigi Rigacci, et al.
Haematologica
|
August 19, 2021
Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study
Lale Kostakoglu, Federico Mattiello, Maurizio Martelli, et al.
The Journal of Molecular Diagnostics : JMD
|
August 31, 2015
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR
Daniela Drandi, Lenka Kubiczkova-Besse, Simone Ferrero, et al.
Haematologica
|
July 10, 2009
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study
Umberto Vitolo, Annalisa Chiappella, Emanuele Angelucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project
Massimo Federico, Monica Bellei, Luigi Marcheselli, et al.
Haematologica
|
July 2, 2013
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi
Annalisa Chiappella, Alessandra Tucci, Alessia Castellino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2013
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi
Massimo Federico, Stefano Luminari, Alessandra Dondi, et al.
Haematologica
|
November 8, 2011
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers
Francesco Zaja, Stefano De Luca, Umberto Vitolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2019
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
Magdalena Klanova, Mikkel Z Oestergaard, Marek Trněný, et al.
Page
of 22